BioSpace News Archive

NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of ambulatory-focused healthcare technology solutions, announced today that President and Chief Executive Officer, Rusty Frantz, will present at an upcoming investor conference.

Medical technology company Defymed, specialized in the design and development of innovative medical devices for the delivery of therapeutic treatments, will be exploring business and scientific opportunities in Boston this September 25 to October 5 as part of the Innouvo program.

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of BAVENCIO® (avelumab) in combination with axitinib for the first-line treatment of adult patients with advanced renal cell carcinoma (RCC)

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the oral once-daily therapy XOSPATA® (gilteritinib) as a monotherapy for the treatment of adult patients who have relapsed or refractory (resistant to treatment) acute myeloid leukemia (AML) with a FLT3 mutation (FLT3mut+).

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research.

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research. [20-September-2019] DALLAS , Sept. 20, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyu

Investment will accelerate product development and innovation for the behavioral health industry

Today, Swedish Medical Center, UCHealth Medical Center of the Rockies, Aspen Valley Hospital, Arkansas Valley Regional Medical Center and Parker Adventist Hospital were recognized with 2019 Ending the Wait awards for their outstanding achievements in facilitating the gift of life through organ and tissue donation in Colorado.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced three presentations on amyotrophic lateral sclerosis (ALS) at the 2019 Muscle Study Group Annual Scientific Meeting, including a podium presentation highlighting collaborative work with a group of ALS patients and caregivers to help inform the design of the REFINE-ALS biomarker study.